Across TCGA pan-cancer cohorts, RNU6-208P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU6-208P’s most consistent transcriptional readouts.

The strongest signal is observed in esophageal carcinoma (ESCA), where RNU6-208P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU6-208P is over-expressed in tumor, although a few such as ESCA and COAD show the opposite, repressed pattern.

ESCA, BRCA, and COAD are the cancer types where RNU6-208P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-208P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
ESCA	All	II,III,IV	−0.535	<.001	2	view →
BRCA	All	III,IV	+0.281	.004	2	view →
COAD	Female	All	−0.261	.033	2	view →
BLCA	All	III,IV	+0.177	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNU6-208P RNA expression & survival · all RNU6-208P data types